Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 112, 104889
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 52 references indexed in Scilit:
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main proteaseAntiviral Research, 2011
- Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysisAnalytical Biochemistry, 2011
- Covalent Protein Labeling Based on Noncatalytic β-Lactamase and a Designed FRET SubstrateJournal of the American Chemical Society, 2009
- Ebselen and diorganylchalcogenides decrease in vitro glutamate uptake by RAT brain slices: Prevention by DTT and GSHToxicology in Vitro, 2007
- Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein OverproductionJournal of Molecular Biology, 2007
- Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitorsTetrahedron, 2006
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLOS Biology, 2005
- Virtual screening of chemical librariesNature, 2004
- Viral cysteine proteinasesPerspectives in Drug Discovery and Design, 1996
- The Behavior and Significance of Slow‐Binding Enzyme Inhibitors1988